Literature DB >> 8083117

Waiting for radiotherapy in Ontario.

W J Mackillop1, H Fu, C F Quirt, P Dixon, M Brundage, Y Zhou.   

Abstract

PURPOSE: Waiting lists for radiotherapy are a fact of life at many Canadian cancer centers. The purpose of this study was to provide a detailed description of the magnitude of the problem in Ontario. METHODS AND MATERIALS: The interval between diagnosis and initiation of radiation treatment was calculated for all patients receiving primary radiotherapy for carcinoma of the larynx, cervix, lung, and prostate at seven Ontario cancer centers between 1982 and 1991. The interval between surgery and initiation of postoperative radiotherapy for breast cancer was also calculated over the same period. The intervals between diagnosis and referral (t1), between referral and consultation (t2), and between consultation and initiation of radiotherapy (t3), were analyzed separately to determine where delay occurred.
RESULTS: Median waiting times between diagnosis and initiation of radical treatment for carcinoma of the larynx, carcinoma of the cervix, nonsmall cell lung cancer, and carcinoma of the prostate were 30.3 days, 27.2 days, 27.3 days, and 93.3 days, respectively. The exceptional interval between diagnosis and treatment of prostate cancer was due to much longer delays between diagnosis and referral. The median waiting time between diagnosis and initiation of postoperative radiotherapy for breast cancer was 61.4 days and the median time between the completion of surgery and initiation of postoperative radiotherapy was 57.8 days. There were significant intercenter variations in median waiting times, but in every situation the median waiting time in Ontario as a whole increased steadily between 1982 and 1991. Median waiting times from diagnosis to the start of curative treatment for laryngeal cancer, cervical cancer, nonsmall cell lung cancer, and prostate cancer increased by 178.7%, 105.6%, 158.3%, and 62.9%, respectively. Waiting time from completion of surgery to initiation of postoperative radiotherapy for breast cancer increased by 102.7%. Most of the increase in treatment delay was found in the interval between consultation and initiation of radiotherapy.
CONCLUSIONS: The Committee on Standards of the Canadian Association of Radiation Oncologists recommends that the interval between referral and consultation should not exceed 2 weeks and that the interval between consultation and initiation of radiotherapy should also not exceed 2 weeks. The majority of patients treated in Ontario met both those standards in 1982, but by 1991 few patients received care within the prescribed intervals.

Entities:  

Mesh:

Year:  1994        PMID: 8083117     DOI: 10.1016/0360-3016(94)90538-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

Review 1.  Social, prognostic, and therapeutic factors associated with cancer survival: a population-based study in metropolitan Detroit, Michigan.

Authors:  Kevin M Gorey; Eric J Holowaty; Ethan Laukkanen; Isaac N Luginaah
Journal:  J Health Care Poor Underserved       Date:  2003-11

2.  Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Authors:  Christopher M Booth; Frances A Shepherd; Yingwei Peng; Gail E Darling; Gavin Li; Weidong Kong; William J Mackillop
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

3.  Determinants of waiting time for a routine family physician consultation in southwestern ontario.

Authors:  Amardeep Thind; Cathy Thorpe; Andrea Burt; Moira Stewart; Graham Reid; Stewart Harris; Judith Belle Brown
Journal:  Healthc Policy       Date:  2007-02

4.  Variability of waiting times for the 4 most prevalent cancer types in Ontario: a retrospective population-based analysis.

Authors:  Amir Rastpour; Mehmet A Begen; Alexander V Louie; Gregory S Zaric
Journal:  CMAJ Open       Date:  2018-06-07

5.  Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institution.

Authors:  S Corradini; O M Niemoeller; M Niyazi; F Manapov; M Haerting; N Harbeck; C Belka; S Kahlert
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

Review 6.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

7.  Wait times for prostate cancer treatment and patient perceptions of care in Canada: a mixed-methods report.

Authors:  K Tran; C Sandoval; R Rahal; G Porter; R Siemens; J Hernandez; S Fung; C Louzado; J Liu; H Bryant
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 8.  Hypofractionated radiation treatment in the management of breast cancer.

Authors:  Apar Gupta; Nisha Ohri; Bruce G Haffty
Journal:  Expert Rev Anticancer Ther       Date:  2018-06-26       Impact factor: 4.512

9.  Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis.

Authors:  Rinaa S Punglia; Akiko M Saito; Bridget A Neville; Craig C Earle; Jane C Weeks
Journal:  BMJ       Date:  2010-03-02

10.  Radiation treatment waiting times for breast cancer patients in Manitoba, 2001 and 2005.

Authors:  A L Cooke; R Appell; K Suderman; K Fradette; S Latosinsky
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.